Klaus Gustav Strein
Directeur/Membre du Conseil chez NOVIMMUNE SA
Postes actifs de Klaus Gustav Strein
Sociétés | Poste | Début | Fin |
---|---|---|---|
NOVIMMUNE SA | Directeur/Membre du Conseil | - | - |
EngMab SARL
EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Président | 01/01/2013 | - |
Fondateur | 01/01/2013 | - | |
Berta Holding AG
Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Klaus Gustav Strein
Anciens postes connus de Klaus Gustav Strein
Sociétés | Poste | Début | Fin |
---|---|---|---|
ROCHE HOLDING AG | Corporate Officer/Principal | 14/09/2011 | 14/09/2011 |
Lamkap Bio Gamma AG | Président | - | - |
Lamkap Bio Alpha AG | Président | - | - |
LamKap Bio beta AG
LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Président | - | - |
BB BIOTECH AG | Directeur/Membre du Conseil | 19/03/2013 | - |
Formation de Klaus Gustav Strein
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistiques
Internationale
Suisse | 8 |
Etats-Unis | 2 |
Allemagne | 2 |
Opérationnelle
Chairman | 4 |
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 5 |
Finance | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
BB BIOTECH AG | Finance |
Entreprise privées | 6 |
---|---|
EngMab SARL
EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Novimmune SA
Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
LamKap Bio beta AG
LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Lamkap Bio Alpha AG | |
Lamkap Bio Gamma AG | |
Berta Holding AG
Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
- Bourse
- Insiders
- Klaus Gustav Strein
- Expérience